196 research outputs found
Mrs Mary Annie Bushell and her claims for assistance, Mrs Bushell's tuberculosis and abusive husband,
No full textThis record was harvested from a previous catalogue system and will be withdrawn in 2025. Information in this record may be superseded or incomplete. Visit this record in UMA's new catalogue at: https://archives.library.unimelb.edu.au/nodes/view/354602Mrs.Mary Annie Bushell and her claims for assistance, Mrs. Bushell's tuberculosis and abusive husband.89169
item: [2015.0033.00543] "Mrs Mary Annie Bushell and her claims for assistance, Mrs Bushell's tuberculosis and abusive husband,
Collecting, connoisseurship and commerce: an examination of the life and career of Stephen Wootton Bushell (1844-1908)
No full textNo abstract available
Text as process : creative composition in Wordsworth, Tennyson and Emily Dickinson
No full textBushell’s aim in Text as Process is to develop a research method for the study of compositional material. Although she draws on an international context – mainly French and German traditions – for current approaches to textual criticism, hers is the first book to apply a new form of critical analysis to authors in the Anglo-American tradition. Bushell revisits issues of intention within process and makes this the center of her new approach, employing “case studies” of the work of three major nineteenth-century poets: Wordsworth, Tennyson and Dickinson. She applies her methodology to each writer in different ways, allowing for cross-comparison as well as the recognition of individual distinctiveness in creativity. In doing so, Bushell demonstrates the need for a unique hermeneutics in relation to the making of the literary work of art. The author concludes with a philosophical account of the status and meaning of the literary work as it comes into being
Vaccines against Drug Abuse—Are We There Yet?
No full textBackground: Drug abuse is a worldwide problem that is detrimental to public health. The potential for drug abuse extends to both legal and illicit drugs. Drawbacks associated with current treatments include limited effectiveness, potential side effects and, in some instances, the absence of or concerns with approved therapy options. A significant amount of clinical research has been conducted investigating immunotherapy as a treatment option against drug abuse. Vaccines against drug abuse have been the main area of research, and are the focus of this review. Methods: An extensive search using “EBSCOhost (Multiple database collection)” with all 28 databases enabled (including “Academic Search Ultimate”, “CINAHL Plus with Full Text”, and MEDLINE), interrogation of the ClinicalTrials.gov website, and searches of individual clinical trial registration numbers, was performed in February and March of 2022. This search extended to references within the obtained articles. Results: A total of 23 registered clinical trials for treating drug abuse were identified: 15 for treatment of nicotine abuse (all vaccine-based trials), 6 against cocaine abuse (4 were vaccine-based trials and 2 were metabolic-enzyme-based trials), 1 against methamphetamine abuse (a monoclonal-antibody-based trial), and 1 multivalent opioid treatment (vaccine-based trial). As indicated on the ClinicalTrials.gov website (Home—ClinicalTrials.gov), the status of all but two of these trials was “Completed”. Phase 3 clinical trials were completed for vaccine treatments against nicotine and cocaine abuse only. Conclusion: Evidence in the form of efficacy data indicates that vaccines are not an option for treating nicotine or cocaine abuse. Efficacy data are yet to be obtained through completion of clinical trials for vaccines against opioid abuse. These findings align with the absence of regulatory approval for any of these treatments. This review further highlights the need for novel treatment strategies in instances where patients do not respond to current treatments, and while the search for efficacious vaccine-based treatments continues
Managing vaccine‐associated anaphylaxis in the pharmacy
No full textBackground: Although vaccine-associated anaphylaxis is very rare, it is the most serious of adverse events. An emerging role for appropriately credentialed pharmacists in Australia is the administration of vaccines to adults. Pharmacists administering vaccinations must be adequately prepared and competent to act should anaphylaxis occur within the community pharmacy setting. Aim: This paper aims to review the evidence, identifies recommendations for established vaccinators administering vaccines in the community setting and provides recommendations for the most appropriate management of anaphylaxis in the community pharmacy setting. Discussion: Available literature revealed that the pharmacist vaccinator should utilise a pre-vaccination checklist to screen for patients at high risk of anaphylaxis. All pharmacists administering vaccines should demonstrate assessed competency using both available brands of adrenaline auto-injectors and demonstrate the adrenaline ampoule/needle/syringe technique. There is a strong case for pharmacist anaphylaxis response kits to contain at minimum three in-date adult adrenaline auto-injectors, in addition to other components of the kit. Pharmacies providing a vaccination service must have an appropriate treatment room and display a posted, written emergency protocol. Pharmacists should be able to identify anaphylaxis and differentiate this medical emergency from other adverse events following immunisation such as vasovagal syncope. Conclusion: To ensure public health, pharmacists administering vaccines must be prepared for, able to screen for and immediately recognise and manage vaccine-associated anaphylaxis and ensure appropriate follow-up and referral.</p
Inside Maine books piece on The Murder of Mary Bean and Other Stories, by El
No full textInside Maine books piece on The Murder of Mary Bean and Other Stories, by Elizabeth De Wolfe, who teaches history at the University of New England. She has written a social history involving a millworker and a failed abortion in the 1850s. With a brief note on The Year of the Goat: 40,000 Miles and the Quest for the Perfect Cheese, by Margaret Hathaway and Karl Schatz, who became goat farmers in Gray
Managing vaccine-associated anaphylaxis in the pharmacy
No full textBackground: Although vaccine-associated anaphylaxis is very rare, it is the most serious of adverse events. An emerging role for appropriately credentialed pharmacists in Australia is the administration of vaccines to adults. Pharmacists administering vaccinations must be adequately prepared and competent to act should anaphylaxis occur within the community pharmacy setting. Aim: This paper aims to review the evidence, identifies recommendations for established vaccinators administering vaccines in the community setting and provides recommendations for the most appropriate management of anaphylaxis in the community pharmacy setting. Discussion: Available literature revealed that the pharmacist vaccinator should utilise a pre-vaccination checklist to screen for patients at high risk of anaphylaxis. All pharmacists administering vaccines should demonstrate assessed competency using both available brands of adrenaline auto-injectors and demonstrate the adrenaline ampoule/needle/syringe technique. There is a strong case for pharmacist anaphylaxis response kits to contain at minimum three in-date adult adrenaline auto-injectors, in addition to other components of the kit. Pharmacies providing a vaccination service must have an appropriate treatment room and display a posted, written emergency protocol. Pharmacists should be able to identify anaphylaxis and differentiate this medical emergency from other adverse events following immunisation such as vasovagal syncope. Conclusion: To ensure public health, pharmacists administering vaccines must be prepared for, able to screen for and immediately recognise and manage vaccine-associated anaphylaxis and ensure appropriate follow-up and referral
Pharmacists' perception of continuing professional development (CPD) during its first year in the Northern Territory
No full textBACKGROUND: Since September 2010 Australian pharmacists are required to acquire mandatory amount of CPD credit poinls annually for continued registration. Due to the lower number of face-to-face CPD activities available in the Northern Territory (NT) and change in the Pharmacy Guild of Australia's funding policy, NT pharmacists' choices of CPD activities may be affected. AIM: This study aims to investigate what motivates NT pharmacisls when choosing CPD activities and if these choices are meeting their learning requirements. METHODS: A Territory-wide questionnaire survey was conducted in 2012, utilising both printed questionnaire and online questionnaire methods. RESULTS: The survey received 68 completed responses, representing approximately 40% of NT pharmacists. The study found the majority of participants considered factors such as relevance to their employment, meeting learning needs, and convenient access as critical when choosing CPD activities, Other factors considered by responders include cost, time limitation and mandatory CPD requirements. The study also found the majority of participants felt thatthey were disadvantaged in accessing CPD in the NT, but reported no difficulties in meeting the CPD requirements for 2010-11. The participants also felt that CPD Group 1 activities sometimes benefit an individual more than Group 2 or Group 3 activities. DISCUSSION/CONCLUSION: The study found that although motivated by a variety of (actors, NT pharmacists felt the CPD activities they have chosen are meeting their learning requirements for 2010-11. However, NT pharmacists do feel disadvantaged when it comes to accessing face-to-face CPD activities.</p
- …
